/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Intercontinental Exchange Appoints John Tuttle Vice Chairman and Chief Commercial Officer of NYSE Group and Michael Blaugrund Chief Operating Officer of NYSE Group
NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE: ICE), a leading operator of
global exchanges and clearing houses and provider of data and listings
services, announced today that John Tuttle has been appointed Vice
Chairman and Chief Commercial Officer of NYSE Group. In this expanded
new role, Tuttle will lead commercial outreach and business development
of NYSE Group, spearhead its efforts to win the largest IPOs, grow the
exchange’s community of 2,300 listed companies, and oversee creation of
new offerings for industries such as biotechnology and other growing
sectors of the economy.
Tuttle’s career at the NYSE, which began in 2007 after service in the
U.S. Government, saw him progress through a series of roles of
increasing responsibility, most recently as Chief Operating Officer of
NYSE Group. Tuttle previously served as Global Head of Listings, Chief
of Staff, Head of Corporate Affairs, and Managing Director of Global
Affairs and Government Relations for NYSE Euronext before its
acquisition by ICE in 2013.
Michael Blaugrund, currently Head of Transactions at the NYSE, has been
promoted to Chief Operating Officer, overseeing strategy and operations
of NYSE Group’s five equities exchanges and two options exchanges.
Blaugrund, who joined the NYSE from Tower Research Capital in 2016,
served as the NYSE’s Head of Equities before ascending to his current
role. His career in financial services includes prior roles with Nasdaq,
Thomson Reuters and Tradeweb.
“It takes a great team to run the world’s leading exchange, and with
colleagues like John and Michael, and everyone who helps make the NYSE
tick, our team at the NYSE is second to none,” said Stacey Cunningham,
President of NYSE Group. “John has helped to cement the NYSE’s
leadership in capital raising, resulting in 75% of tech proceeds coming
to the NYSE since 2014, and Michael has led the expansion of our equity
platforms, offering our customers freedom to choose features that best
align with their businesses, while directing the design and rollout of
the new NYSE Pillar technology platform. The NYSE has benefited over
many years from John and Michael’s leadership and expertise, and I look
forward to them building on that impressive track record for years to
come.”
The appointments of both John Tuttle and Michael Blaugrund take effect
today.
About Intercontinental Exchange
Intercontinental
Exchange (NYSE: ICE) is a Fortune 500 company formed in the year
2000 to modernize markets. ICE serves customers by operating the exchanges,
clearing houses and
information services they rely upon to invest, trade and manage risk
across global financial and commodity markets. A leader in market data, ICE
Data Services serves the information and connectivity needs across
virtually all asset classes. As the parent company of the New
York Stock Exchange, the company is the premier venue for raising
capital in the world, driving economic growth and transforming markets.
Trademarks of ICE and/or its affiliates include Intercontinental
Exchange, ICE, ICE block design, NYSE and New York Stock Exchange.
Information regarding additional trademarks and intellectual property
rights of Intercontinental Exchange, Inc. and/or its affiliates is
located at http://www.intercontinentalexchange.com/terms-of-use.
Key Information Documents for certain products covered by the EU
Packaged Retail and Insurance-based Investment Products Regulation can
be accessed on the relevant exchange website under the heading “Key
Information Documents (KIDS).”
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995 — Statements in this press release regarding ICE’s business
that are not historical facts are “forward-looking statements” that
involve risks and uncertainties. For a discussion of additional risks
and uncertainties, which could cause actual results to differ from those
contained in the forward-looking statements, see ICE’s Securities and
Exchange Commission (SEC) filings, including, but not limited to, the
risk factors in ICE’s Annual Report on Form 10-K for the year ended
December 31, 2018, as filed with the SEC on February 7, 2019.
ICE-CORP
Contacts
ICE Media Contact:
Josh King
[email protected]
212-656-2490
ICE Investor Contact:
Warren Gardiner
[email protected]
770-835-0114
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis7 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis6 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan6 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis2 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa